The anti-tumour effect of a DNA vaccine carrying a fusion gene of human VEGFR2 and IL-12

Because of tumour dependence on angiogenesis, anti-angiogenic therapy has become the most attractive area of basic and clinical study in the field of cancer research. In order to create a synergistic effect on angiogenesis and immune regulation, we designed and constructed a new type of DNA vaccine...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Sha Wen, Jia Zhang, Ping Zhou, Cheng Luo, Yingfu Liu, Zhongwei Xu, Xiaoyi Chen, Houxun Ma
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Taylor & Francis Group 2016-09-01
Seri Bilgileri:Biotechnology & Biotechnological Equipment
Konular:
VEGFR2
IL-12
tumour
DNA vaccine
Online Erişim:http://dx.doi.org/10.1080/13102818.2016.1207488
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller